Trial Profile
The effects of exenatide and exenatide + exendin 9 on endothelial function in patients with type 2 diabetes mellitus or impaired glucose tolerance under fasting conditions
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jul 2013
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Avexitide
- Indications Glucose intolerance; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 Jul 2013 New trial record
- 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.